Alec Baldwin and the producers of the film Rust, are being sued by its prop gun supplier.

Seth Kenney, who owns PDQ Arm and Prop, LLC, supplied the prop gun that killed cinematographer Halyna Hutchins on the set of the neo-Western movie in New Mexico in 2021, and he has alleged that the team “conspired” to launch a “scapegoat smear campaign” against him and his company.

In a complaint filed on October 22 in New Mexico, Kenney accused Baldwin and the producers of “false light, conversion, unjust enrichment, and tortious interference.”

He is seeking compensation and damages, claiming he’s struggled to find work in the film industry since, but has chosen not to have a legal representative.

In the document, he claims his “firearm rental property was in good working order” before the tragedy.

Kenney states that he rented out the prop “under the provisions of strict safety guidelines and practices; and with the understanding that [producers] would observe and comply with local, state, and federal law.”

It is pertinent to mention that Alec Baldwin was rehearsing a scene when the gun he was holding discharged, killing Hutchins and injuring director Joel Souza.

He is adamant that he did not pull the trigger of the gun or know why it contained live ammunition.

The 67-year-old actor faced an involuntary manslaughter charge, which was thrown out by the judge in 2024.

Armorer Hannah Gutierrez-Reed was convicted in March last year after being found guilty of involuntary manslaughter for loading a live round into Alec’s gun and was handed a 14-month prison sentence.

King Charles has taken the unprecedented step of formally removing Prince Andrew’s royal titles, delivering what a royal commentator called a “hammer blow” to his brother.

The monarch’s decision affects all of Andrew’s titles, including Prince, Duke of York, Earl of Inverness, and Baron Killyleagh, as well as his honours like the Order of the Garter and the Knight Grand Cross of the Victorian Order.

This comes as controversy around Andrew’s past ties to Jeffrey Epstein continues to grow.

Speaking on Britain’s News Channel, royal expert Cameron Walker said, “Of course, this is incredibly significant. The King has initiated a formal process to remove the title of Prince, presumably via letters patent.”

Unlike Andrew, his daughters, Princess Beatrice and Princess Eugenie, will keep their titles under the rules set out by King George V in 1917.

“His daughters, Princess Beatrice and Princess Eugenie, retain their titles in line with King George V’s 1917 Letters Patent,” added Walker.

He continued, “Prince Andrew had previously relinquished the use of his titles and honours temporarily, but that was not a formal removal, which is what the King is now implementing.

“This is a very strong move from King Charles, delivering a hammer blow to his brother.

“It is unprecedented in living memory for a Prince title to be formally removed from a member of the Royal Family.

“The long-term resolution will involve the King formally removing the Prince title via letters patent.

“Prince Andrew will no longer be styled as Prince Andrew and will instead be known as Andrew Mountbatten Windsor, following controversies surrounding his friendship with Jeffrey Epstein and the sexual assault allegations, which he denies.”

U.S. Food and Drug Administration (FDA) has declared more than 580,000 bottles of a common blood pressure medication have been pulled from the market due to contamination with a potentially cancer-causing chemical.

The recall includes various strengths of “Prazosin Hydrochloride” capsules. The drug is commonly used to treat high blood pressure and prostate conditions, which is also sometimes prescribed off-label for PTSD related nightmares.

New Jersey based Teva Pharmaceuticals USA initiated the recall earlier this month. On October 24, FDA classified it as a Class II recall.

Why Prazosin Hydrochloride was recalled

As mentioned in the enforcement report of FDA, the testing of the medication revealed that the capsules contained elevated levels of an impurity known as “N-nitroso prazosin.”

The chemical structure is R2N−N=O, where R is usually an alkyl group. Nitrosamines have a nitroso group (NO+) that are “probable human carcinogens,” bonded to a deprotonated amine. Most nitrosamines are carcinogenic in animals.

Their possibility of formation can be during the manufacturing process or during storage.

FDA explained that exposure to this chemical “may cause temporary or medically reversible adverse health consequences or where the probability of serious health consequences is remote.”

Which medications are affected?

The recall spans three different dosage strengths of Prazosin Hydrochloride capsules that were distributed nationwide. The affected products are:

• 181,658 bottles of 1 mg capsules with lot numbers 3010544A and 3010545A, expiring in October 2025.
• 291,512 bottles of 2mg capsules across multiple lot numbers, with expiration dates from October 2025 through July 2026.
• 107,673 bottles of 5 mg capsules across multiple expiry dates extending into 2026. 

What patients should do

Patients should not abruptly stop their medication as it can pose serious health threats. FDA recommends patients to take following steps:

• Immediately consult your doctor to get to know if your specification medication is part of recalled lots.
• Ask your doctor about any safer alternative option.
• Discontinue medicine under direct supervision of a healthcare professional

Other common medications like Zantac have also been recalled due to nitrosamine impurities in the past.